Graham David Ogle
Overview
Explore the profile of Graham David Ogle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
119
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Besancon S, Haynes A, Togo A, Sandy J, Maniam J, Sidibe A, et al.
Diabet Med
. 2025 Mar;
:e70007.
PMID: 40033680
Aims: Evidence on outcomes of treating type 1 diabetes (T1D) with long-acting basal insulins in low-resourced settings is lacking. This study aimed to evaluate the impact of switching children and...
2.
Besancon S, Govender D, Sidibe A, Noble J, Togo A, Lane J, et al.
Pediatr Diabetes
. 2022 Sep;
23(8):1552-1559.
PMID: 36062396
Objective: Limited information is available regarding youth-onset diabetes in Mali. We investigated demographic, clinical, biochemical, and genetic features in new diabetes cases in children and adolescents. Research Design And Methods:...
3.
Habineza J, James S, Sibomana L, Klatman E, Uwingabire E, Maniam J, et al.
Pan Afr Med J
. 2022 Mar;
40:252.
PMID: 35251446
Introduction: data on the impact of COVID-19 on people with type 1 diabetes (T1D) in less resourced countries are limited. Our study was undertaken in Kigali, Rwanda, and aimed to...
4.
Jean-Baptiste E, Larco P, von Oettingen J, Ogle G, Moise K, Fleury-Milfort E, et al.
Diabetes Ther
. 2021 Aug;
12(9):2545-2556.
PMID: 34382158
Introduction: Controlling insulin-treated diabetes is challenging in low-resource settings where only Neutral Protamine Hagedorn (NPH), regular (R) and premixed insulin formulations are available, self-monitoring of blood glucose (SMBG) supplies are...
5.
Ibrahim T, Govender D, Abdullah M, Noble J, Hussien M, Lane J, et al.
Pediatr Diabetes
. 2021 Apr;
22(5):749-757.
PMID: 33837995
Objective: To further understand clinical and biochemical features, and HLA-DRB1 genotypes, in new cases of diabetes in Sudanese children and adolescents. Research Design And Methods: Demographic characteristics, clinical information, and...
6.
Zabeen B, Maniam J, Balsa A, Tayyeb S, Huda K, Azad K, et al.
J Pediatr Endocrinol Metab
. 2021 Mar;
34(4):509-515.
PMID: 33662193
Objectives: Bangladesh has limited information regarding incidence of type 1 diabetes (T1D) and type 2 diabetes (T2D) in young people. The objective of this study was to measure minimum incidence...
7.
Sandy J, Besancon S, Sidibe A, Minkailou M, Togo A, Ogle G
Pediatr Diabetes
. 2021 Feb;
22(4):545-551.
PMID: 33586301
Aims: Determine incidence, prevalence and mortality of Type 1 diabetes (T1D) in children and youth <25 years (y) in Mali during the first 10 years of the Santé Diabète/Life for...
8.
Klatman E, Ogle G
World J Diabetes
. 2020 Sep;
11(8):358-369.
PMID: 32864048
Background: Young people with type 1 diabetes in low-and-middle income countries face many challenges in accessing care, with various essential supplies needed for survival and long-term health. Aim: To study...
9.
Condie A, Allen T, Ogle G
Diabetes Res Clin Pract
. 2020 Apr;
163:108155.
PMID: 32333971
Objectives: Determine the types, incidence, mortality rate, and clinical status of youth diabetes at Bach Christian Hospital (BCH), Qalandarabad, Pakistan. Methods: Analysis of incidence and mortality data of all patients...
10.
Zabeen B, Govender D, Hassan Z, Noble J, Lane J, Mack S, et al.
Diabetes Res Clin Pract
. 2019 Nov;
158:107894.
PMID: 31669629
Aims: Little information is published on diabetes in young people in Bangladesh. We aimed to investigate the demographic, clinical, and biochemical features, and HLA-DRB1 alleles in new cases of diabetes...